By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Inotek Pharmaceuticals Corporation 

100 Cummings Center, Suite 419E

Beverly  Massachusetts  01915  U.S.A.
Phone: 978-232-9660 Fax: 978-232-8975


SEARCH JOBS


Industry
Pharmaceutical






Company News
Inotek Pharmaceuticals Corporation Announces Conversion Of $21 Million Principal Amount Of 5.0% Convertible Senior Notes Due 2020 7/30/2015 11:18:53 AM
Inotek Pharmaceuticals Corporation Announces Positive End-Of-Phase II Meeting With FDA And Phase III Development Strategy For Trabodenoson, A Novel Treatment For Glaucoma 7/23/2015 10:31:06 AM
Inotek Pharmaceuticals Corporation Appoints Dr. Cadmus Collins Rich As Vice President, Medical Affairs And Clinical Development 7/22/2015 10:34:01 AM
Inotek Pharmaceuticals Corporation Appoints Richard N. Spivey Pharmd, Ph.D. To Board Of Directors 7/21/2015 8:09:06 AM
Inotek Pharmaceuticals Corporation Appoints Claudine Prowse, Ph.D. As Vice President, Strategy And Investor Relations Officer 7/20/2015 10:42:47 AM
Inotek Pharmaceuticals Corporation Reports First Quarter 2015 Operational And Financial Results 5/15/2015 11:29:03 AM
Inotek Pharmaceuticals Corporation Reports 2014 Financial Results 4/1/2015 3:28:09 PM
Inotek Pharmaceuticals Corporation Announces Closing Of Initial Public Offering And Convertible Senior Notes Offering 2/24/2015 11:38:48 AM
Inotek Pharmaceuticals Corporation Announces Pricing Of Initial Public Offering Of 6,667,000 Shares Of Common Stock And 5.0% Convertible Senior Notes Due 2020 2/18/2015 9:05:31 AM
Newcomers Like Aerie Pharmaceuticals, Inc. (AERI), Inotek Pharmaceuticals Corporation Aim to Shake Up Big Pharma With New Wave of Glaucoma Drugs 2/10/2015 7:05:24 AM
123456
//-->